FACIT
Toronto, Ontariofacit.ca
Overview
FACIT is an award-winning commercialization venture firm that builds companies with entrepreneurs to accelerate oncology innovation. Established by the Ontario Institute for Cancer Research (OICR), it aims to bridge the life sciences seed funding gap by seeding and scaling Ontario's premier entrepreneurial ventures. FACIT strategically invests in oncology breakthroughs and companies, including therapeutics, imaging, diagnostics, and technology platforms, arising from Ontario's innovation ecosystem. It manages a diverse portfolio of over 35 companies and its portfolio has raised more than $1.7B in follow-on financing.
Portfolio Companies
10
Website
facit.caInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NerView Surgical Inc. | Apr 2026 | Grant | Co-investor |
| Genetics Adviser | Mar 2025 | Accelerator | Lead |
| AiimSense Inc. | Mar 2025 | Accelerator | Co-investor |
| Esphera SynBio | Jan 2025 | Seed | Lead |
| cTRL Therapeutics | Oct 2024 | Early Funding | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.